MedTrace Logo

Endoscopic Gastric Tubulization

NCT03554902 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-05-01

No results posted yet for this study

Summary

Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.

The objective of this study is to prospectively collect data of patients who underwent an endoscopic gastric tubulization, from last visit before procedure to 2 years after procedure. These data are usually collected during medical consultations and will enable the evaluation of weight loss, quality of life and comorbidities improvement, reproducibility and durability of the technique.

Conditions

  • Morbid Obesity

Interventions

PROCEDURE

Endoscopic gastric tubulization

Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA).

Sponsors & Collaborators

  • IHU Strasbourg

    lead OTHER

Principal Investigators

  • Silvana Perretta, MD, PhD · Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

  • Michel Vix, MD · Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-08
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03554902 on ClinicalTrials.gov